Orion Pharma wrapped the Phase1 Trainee Programme 2026 for its summer trainees across research and engineering to business operations and beyond.

Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining our trusted expertise with continuous innovation. We have an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by us are used to treat cancer, respiratory diseases and neurological diseases, among others. In 2025 our net sales amounted to EUR 1,890 million and we employ about 4,000 professionals worldwide, dedicated to building well-being. Product related questions and feedback: https://www.orionpharma.com/feedback Beware of any recruitment scam using Orion Pharma’s name Be cautious of recruitment scams where individuals pose as Orion Pharma employees or authorized recruiters. Orion Pharma will never request payment, personal financial information, or any favours at any stage of our hiring process.